One of the world's most promising anti-aging drugs, how it works
In this segment, Bryan Johnson discusses the cautious approach researchers took when dosing humans with rapamycin due to side effects observed in organ transplant patients, such as high cholesterol, tissue swelling, soft‑tissue infections, and impaired wound healing. He notes that more recent studies indicate that intermittent or lower‑dose regimens can substantially reduce these adverse effects, making rapamycin’s potential benefits for longevity more compelling. Johnson then explains rapamycin’s core mechanism: direct inhibition of the mTORC1 growth pathway, which is over‑active in many age‑related diseases. He contrasts this pharmacological inhibition with natural methods that also suppress mTORC1, including caloric restriction, fasting, exercise, and AMPK activation, positioning rapamycin as a powerful, targeted tool for extending healthspan.
